RKRyoko Kumagai

Ryoko Kumagai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ryoko Kumagai has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Hisafumi Yasuda

    Department of Public Health, Kobe University Graduate School of Health Sciences, Suma-ku, Kobe, Japan

    1 shared publication
  • Hisatomo Kowa

    Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Suma-ku, Kobe, Japan

    1 shared publication
  • Hisatomo Kowa

    Kobe University Graduate School of Health Sciences

    1 shared publication
  • Rei Ono

    Department of Public Health, Kobe University Graduate School of Health Sciences, Suma-ku, Kobe, Japan

    1 shared publication
  • Tohmi Osaki

    Department of Occupational Therapy, Faculty of Rehabilitation, Kobe Gakuin University, Ikawadani-cho, Nishi-ku, Kobe, Japan

    1 shared publication
  • Yoji Nagai

    Department of Clinical Research Facilitation, Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital, Shogoin, Sakyo-ku, Kyoto, Japan

    1 shared publication

Latest Publications

  • Longitudinal deterioration of subjective cognitive decline in apolipoprotein ε4 carriers and improvement of subjective cognitive decline by multi-domain intervention for prevention of dementia: The cognitive function instrument assessment

    by Tohmi Osaki, Yutaro Oki, Ryoko Kumagai, Rei Ono, Hisafumi Yasuda, Yoji Nagai, Hisatomo Kowa

    Background: Subjective cognitive decline represents an early stage of mild cognitive impairment, with the Cognitive Function Instrument (CFI) serving to subjectively evaluate the decline in daily living activities associated with this minor cognitive decline. Objective: To examine how CFI scores change with apolipoprotein E ε4 (ApoE4) carriage, objective cognitive decline, and dementia prevention intervention. We aimed to assess CFI's usefulness in the early dementia risk identification. Methods: This study involved 196 older adults with normal cognition in a randomized controlled intervention trial. CFI was assessed every six months from baseline to 18 months, using the Alzheimer's Disease Cooperative Study-Preclinical Alzheimer Cognitive Composite (ADCS-PACC) to measure cognitive decline. We employed a mixed model for repeated measures to compare the CFI scores at 18 months in the ApoE4, ADCS-PACC, and allocation groups. Results: CFI scores increased in ApoE4 carriers and decreased in the intervention group, with significant differences observed in the CFI score changes at 18 months between carriers and non-carriers and among the allocation groups (p = 0.002, p = 0.026, respectively). However, there was no significant difference in the CFI score change among ADCS-PACC groups (p = 0101). Conclusions: We observed CFI scores worsening over time in individuals with ApoE4 and showing a tendency to deteriorate over time in those with objective cognitive decline. These findings suggest that the CFI may be able to identify high-risk individuals for dementia at an early stage. Furthermore, the improvement in the CFI score is considered a significant finding when considering future measures for subjective cognitive decline.

  • Open Access

    Survey on the current situation for early diagnosis of dementia and contributing factors in Japan

    by Ryoko Kumagai, Yuma Sonoda, Hisatomo Kowa

    BackgroundEarly diagnosis of dementia is important for both initiation of non-pharmacological activities to slow cognitive decline as well as the development of disease-modifying drugs; however, it appears there may be a tendency for formal diagnosis to be delayed. Since the current status of diagnosis in Japan is unclear, we conducted a survey with family caregivers of patients with dementia using questionnaires and interviews to investigate the factors regarding the dementia diagnosis process in Japan.MethodsWe distributed questionnaires to family caregivers of people with dementia and conducted additional follow-up interviews with approximately half of them. We calculated odds ratios for the time to diagnosis using logistic regression analysis for each characteristic from the questionnaire data. We also created co-occurrence networks from the interview data in order to provide qualitative context to the questionnaire data.ResultsWe collected 68 questionnaires and conducted 32 interviews. The median time to diagnosis was 12 months, and logistic regression analysis showed a significant trend toward shorter time to diagnosis in the absence of other caregivers. In addition, there were significant differences in age, relationship with patients and the time from the first visit to the final diagnosis between groups with and without other caregivers.ConclusionsThe results of this study suggest that the presence or absence of other caregivers may affect caregivers' behaviour and the time taken to receive a diagnosis of dementia. These findings indicate it may be beneficial to predict inhibiting factors and change approaches based on caregivers' and patients' background to promote early diagnosis.